When will the Wegovy and Zepbound shortages end?

According to the US Food and Drug Administration (FDA), shortages of the popular injected weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide) won’t end anytime soon.

Right now, the three smallest doses of Wegovy that people need to start treatment have limited availability, and there is no estimated timeline for the shortage to end, according to an April 29 FDA update.

All smaller doses of Zepbound and Mounjaro, a type 2 diabetes drug with the same active ingredient as Zepbound, will be in short supply until at least the end of June, the FDA also reported.

All three drugs are hard to come by right now because of increased demand, the FDA said. However, there is currently no shortage of Ozempic, the type 2 diabetes drug made from semaglutide, the same active ingredient in Wegovy, according to the FDA.

The shortage has waxed and waned and been somewhat unpredictable in recent months, says Jody Dushay MD, an endocrinologist at Beth Israel Deaconess Medical Center in Boston and an assistant professor at Harvard Medical School.

Weight loss drug shortages by 2024

I have no idea when all the doses of all these drugs will be available, but I am quite pessimistic and guess there will be shortages of some or all of these drugs until 2024, says Dr. Dushay, depending on the difficulties that Boston faces. -patients in the area have gotten the most doses of Zepbound, Wegovy and Mounjaro.

#Wegovy #Zepbound #shortages
Image Source : www.everydayhealth.com

Leave a Comment